Effects of interleukin‐6 receptor blockade on allergen‐induced airway responses in mild asthmatics

Abstract

In a small proof-of-concept clinical trial, we found no evidence that a single dose of tocilizumab was able to prevent allergen-induced bronchoconstriction. (Trial registered in the Australian New Zealand Clinical Trials Registry, number ACTRN12614000123640).